ADA’s Scientific Sessions: Day 1
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
Coping with T1D During Stressful and Uncertain Times
Expert advice from a Licensed Professional Counselor who also lives with T1D.
Snails—Yes, Snails—Are Helping Unlock Faster Insulins
Scientists have uncovered a potential breakthrough in developing a faster acting insulin in an unusual place: snails. Now, Breakthrough T1D-funded…
Breakthrough T1D Top Advances Over the Past Year
At Breakthrough T1D, we are committed to funding the development of new therapies to keep people with type 1 diabetes…
From the Archives: Mapping Directions for Diabetes Research
A historical account about a past initiative that would help pave the way for Breakthrough T1D’s future approach to identifying…
Navigating the Psychosocial Impacts of T1D on Children During Quarantine
Becky Lois, Ph.D., discussed how parents can help children cope with the psychosocial challenges of living with T1D during quarantine.
Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study
Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.
Viacyte Receives Funding to Continue Developing Beta Cell Therapies
ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of…
Just Announced: More Affordable Insulin Options for Medicare Beneficiaries Coming Soon
Breakthrough T1D welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options…
Breakthrough T1D Partner: Huge Upsides to Telemedicine
Virtual Visits Can Transform Care and Improve Outcomes for People with T1D
